Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Pourrat

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Autoimmunity|April 29, 2020
Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group RegistryYann Nguyen, Christian Pagnoux, Alexandre Karras, et al.
Critical Care Medicine|September 20, 2011
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference CenterAntoine Froissart, Marc Buffet, Agnès Veyradier, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
Journal of Autoimmunity|September 3, 2015
Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study GroupGonzalo de Luna, Dominique Chauveau, Julien Aniort, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamideNathalie Morel, Anne Bachelot, Zeina Chakhtoura, et al.
Haematologica|May 15, 2012
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceYgal Benhamou, Cyrielle Assié, Pierre-Yves Boelle, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)Nathalie Costedoat-Chalumeau, Lionel Galicier, Olivier Aumaître, et al.
Transfusion|May 29, 2013
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference CenterMarjolaine Morgand, Marc Buffet, Marc Busson, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Autoimmunity|April 29, 2020
Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group RegistryYann Nguyen, Christian Pagnoux, Alexandre Karras, et al.
Critical Care Medicine|September 20, 2011
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference CenterAntoine Froissart, Marc Buffet, Agnès Veyradier, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
Journal of Autoimmunity|September 3, 2015
Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study GroupGonzalo de Luna, Dominique Chauveau, Julien Aniort, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamideNathalie Morel, Anne Bachelot, Zeina Chakhtoura, et al.
Haematologica|May 15, 2012
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceYgal Benhamou, Cyrielle Assié, Pierre-Yves Boelle, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)Nathalie Costedoat-Chalumeau, Lionel Galicier, Olivier Aumaître, et al.
Transfusion|May 29, 2013
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference CenterMarjolaine Morgand, Marc Buffet, Marc Busson, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Pageof 3